Ignite Creation Date:
2024-05-05 @ 12:04 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00235508
Status:
COMPLETED
Last Update Posted:
2012-02-22
First Post:
2005-10-06
Brief Title:
Safety and Efficacy of Eszopiclone in Patients With Generalized Anxiety Disorder
Sponsor:
Sumitomo Pharma America Inc
Organization:
Sumitomo Pharma America Inc
Organization Data
Organization:
Sumitomo Pharma America Inc
Class:
INDUSTRY
Study ID:
190-902
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Sumitomo Pharma America Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None